GUGGENHEIM CAPITAL LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 154 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$353,000
+606.0%
58,530
+388.3%
0.00%
Q1 2017$50,000
-21.9%
11,987
-22.8%
0.00%
Q4 2016$64,000
-97.3%
15,525
-94.7%
0.00%
-100.0%
Q3 2016$2,380,000
+9.7%
293,842
+5.6%
0.01%0.0%
Q2 2016$2,170,000
-14.6%
278,221
-15.4%
0.01%
-12.5%
Q1 2016$2,540,000
-43.4%
329,041
-20.9%
0.01%
-38.5%
Q4 2015$4,487,000
+2.4%
415,839
-34.4%
0.01%0.0%
Q3 2015$4,381,000
+43.8%
633,998
+84.3%
0.01%
+62.5%
Q2 2015$3,047,000
+342.9%
343,932
+392.4%
0.01%
+300.0%
Q1 2015$688,000
-83.1%
69,842
-79.0%
0.00%
-80.0%
Q4 2014$4,080,000
+59.3%
333,081
+29.8%
0.01%
+66.7%
Q3 2014$2,561,000
+7660.6%
256,636
+2462.5%
0.01%
Q1 2014$33,000
-10.8%
10,015
-10.9%
0.00%
Q4 2013$37,000
-96.7%
11,237
-97.0%
0.00%
-100.0%
Q3 2013$1,117,000
-72.7%
369,813
-25.9%
0.00%
-76.5%
Q2 2013$4,085,000499,4040.02%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q4 2015
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$57,396,0007.04%
HealthInvest Partners AB 497,807$2,096,0003.21%
BVF INC/IL 3,285,400$13,832,0002.35%
EMORY UNIVERSITY 486,438$2,048,0001.93%
Marcus Capital, LLC 69,400$1,751,0001.63%
DAFNA Capital Management LLC 196,500$827,0000.70%
Orbimed Advisors 13,107,200$55,181,0000.62%
Rock Springs Capital Management LP 1,500,000$6,315,0000.36%
Spark Investment Management LLC 710,100$2,989,0000.19%
TURNER INVESTMENTS LLC 65,420$275,0000.18%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders